MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceed from sale ofshort-term investments$4,000,000 Net cash provided byinvesting activities$4,000,000 Net increase in cashand cash...$1,707,352 Canceled cashflow$2,292,648 Prepaid expenses andother current assets-$232,398 Income receivables-$53,082 Stock-based compensationexpense$17,386 Common stock issued forservices$5,000 Net proceeds fromissuance of common stock$79,210 Net cash used inoperating activities-$2,200,644 Net cash (used)provided by financing...-$92,004 Canceled cashflow$307,866 Canceled cashflow$79,210 Net loss-$2,201,243 Payments on short-termnotes payable$171,214 Accounts payable andaccrued expenses-$307,267
Cash Flow
source: myfinsight.com

ORAGENICS INC (OGEN)

ORAGENICS INC (OGEN)